{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:41:56Z","timestamp":1760888516715,"version":"3.38.0"},"reference-count":74,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.nephro.2010.12.005","type":"journal-article","created":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T09:18:59Z","timestamp":1295342339000},"page":"154-161","source":"Crossref","is-referenced-by-count":2,"title":["Efficacit\u00e9 et tol\u00e9rance du carbonate de lanthane dans le traitement de l\u2019hyperphosphor\u00e9mie chez le patient insuffisant r\u00e9nal chronique"],"prefix":"10.1684","volume":"7","author":[{"given":"Maurice","family":"Laville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2010.12.005_bib0005","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0015","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.12.005_bib0020","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0035","first-page":"446","article-title":"Prise en charge de l\u2019hyperphosphat\u00e9mie chez le patient insuffisant r\u00e9nal chronique dialys\u00e9. R\u00e9sultats de l\u2019\u00e9tude fran\u00e7aise PROPHETIE. 11e r\u00e9union commune de la Soci\u00e9t\u00e9 de francophone de dialyse et de la Soci\u00e9t\u00e9 n\u00e9phrologie, Toulouse","volume":"5","author":"Urena","year":"2009","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2010.12.005_bib0040","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD -MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease -mineral and bone disorder (CKD -MBD). Kidney International 2009;76(Suppl 113): S1\u2013S130."},{"key":"10.1016\/j.nephro.2010.12.005_bib0045","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.12.005_bib0050","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1525-139X.2006.00169.x","article-title":"Lanthanum: a safe phosphate binder","volume":"19","author":"Persy","year":"2006","journal-title":"Semin Dial"},{"key":"10.1016\/j.nephro.2010.12.005_bib0060","unstructured":"Shire. Fosr\u00e9nol\u00ae\u00a0: r\u00e9sum\u00e9 des caract\u00e9ristiques du produit. 2004."},{"key":"10.1016\/j.nephro.2010.12.005_bib0065","series-title":"36th Annual Meeting of the American Society of Nephrology, San Diego, CA, 2003","article-title":"The pharmacology of lanthanum carbonate: a novel non-aluminium, non-calcium phosphate binder","author":"Damment","year":"2003"},{"issue":"Supplement 90","key":"10.1016\/j.nephro.2010.12.005_bib0070","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1523-1755.2004.09005.x","article-title":"A comparison of clinically useful phosphorus binders for patients with chronic kidney failure","volume":"66","author":"Emmett","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0075","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/jps.20956","article-title":"Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride","volume":"96","author":"Autissier","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nephro.2010.12.005_bib0080","unstructured":"Genzyme. R\u00e9nagel\u00ae\u00a0: r\u00e9sum\u00e9 des caract\u00e9ristiques du produit. 2008."},{"key":"10.1016\/j.nephro.2010.12.005_bib0085","article-title":"The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol","author":"Pierce","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0090","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2165\/00003495-200464090-00008","article-title":"Lanthanum carbonate","volume":"64","author":"Swainston Harrison","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.nephro.2010.12.005_bib0095","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfn737","article-title":"Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats","volume":"24","author":"Neven","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200847090-00001","article-title":"Clinical pharmacokinetics of the phosphate binder lanthanum carbonate","volume":"47","author":"Damment","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nephro.2010.12.005_bib0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.2008.571","article-title":"Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure","volume":"75","author":"Bervoets","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1523-1755.2005.00171.x","article-title":"Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration","volume":"67","author":"Lacour","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0091270006289846","article-title":"Absolute bioavailability and disposition of lanthanum in healthy human subjects administered lanthanum carbonate","volume":"46","author":"Pennick","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0120","first-page":"286","article-title":"Lanthanum carbonate treatment, for up to 6\u00a0years, is not associated with adverse effects on the liver in patients with chronic kidney disease stage 5 receiving hemodialysis","volume":"71","author":"Hutchison","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxlet.2007.04.005","article-title":"Systemic lanthanum is excreted in the bile of rats","volume":"171","author":"Damment","year":"2007","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.nephro.2010.12.005_bib0130","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","article-title":"Progressive accumulation of lanthanum in the liver of normal and uremic rats","volume":"68","author":"Slatopolsky","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0135","doi-asserted-by":"crossref","unstructured":"Nikolov IG, Joki N, Vicca S, Patey N, Auchere D, Benchitrit J, et al. Tissue accumulation of lanthanum as compared to aluminum in rats with chronic renal failure \u2013 possible harmful effects after long-term exposure. Nephron Exp Nephrol 2010;115:e112\u2013121.","DOI":"10.1159\/000313492"},{"key":"10.1016\/j.nephro.2010.12.005_bib0140","first-page":"284","article-title":"Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years","volume":"70","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10157-009-0240-0","article-title":"Accumulation of lanthanum carbonate in the digestive tracts","volume":"14","author":"Kato","year":"2010","journal-title":"Clin Exp Nephrol"},{"issue":"Pt 2","key":"10.1016\/j.nephro.2010.12.005_bib0150","first-page":"227","article-title":"Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers","volume":"184","author":"Xu","year":"1994","journal-title":"J Anat"},{"key":"10.1016\/j.nephro.2010.12.005_bib0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.toxlet.2009.03.020","article-title":"Dietary administration in rodent studies distorts the tissue deposition profile of lanthanum carbonate; brain deposition is a contamination artefact?","volume":"188","author":"Damment","year":"2009","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.nephro.2010.12.005_bib0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00003088-200847080-00004","article-title":"A model of the kinetics of lanthanum in human bone, using data collected during the clinical development of the phosphate binder lanthanum carbonate","volume":"47","author":"Bronner","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nephro.2010.12.005_bib0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2215\/CJN.01580407","article-title":"Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin","volume":"2","author":"How","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0170","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ndt\/gfh693","article-title":"Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study","volume":"20","author":"Al-Baaj","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5414\/CNP63461","article-title":"Lanthanum carbonate efficacy and tolerability in the treatment of hyperphosphatemic patients with end-stage renal disease","volume":"63","author":"Chiang","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CNP62193","article-title":"Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis","volume":"62","author":"Finn","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(03)00554-7","article-title":"Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia","volume":"42","author":"Joy","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.12.005_bib0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1744-9987.2007.00541.x","article-title":"Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis","volume":"12","author":"Shigematsu","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.nephro.2010.12.005_bib0195","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1093\/ndt\/gfn310","article-title":"Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden","volume":"23","author":"Hutchison","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2215\/CJN.02830608","article-title":"Lanthanum carbonate reduces phosphorus burden in patients with CKD stages\u00a03 and 4: a randomized trial","volume":"4","author":"Sprague","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5414\/CNP70404","article-title":"Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia","volume":"70","author":"Shigematsu","year":"2008","journal-title":"Clin Nephrol"},{"issue":"Supplement 85","key":"10.1016\/j.nephro.2010.12.005_bib0210","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","article-title":"A multicenter study on the effects of lanthanum carbonate and calcium carbonate on renal bone disease in dialysis patients","volume":"63","author":"D\u2019Haese","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0215","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000084653","article-title":"Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate","volume":"100","author":"Hutchison","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2010.12.005_bib0220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5414\/CNP65191","article-title":"Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients","volume":"65","author":"Finn","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0225","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CNP72252","article-title":"Lanthanum carbonate vs sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study","volume":"72","author":"Sprague","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0230","doi-asserted-by":"crossref","first-page":"c15","DOI":"10.1159\/000149239","article-title":"Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6\u00a0years of treatment","volume":"110","author":"Hutchison","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2010.12.005_bib0235","unstructured":"Shire. Fosr\u00e9nol\u00ae\u00a0: r\u00e9sum\u00e9 des caract\u00e9ristiques du produit. 2010."},{"key":"10.1016\/j.nephro.2010.12.005_bib0240","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMicm050535","article-title":"Images in clinical medicine. Radiographic appearance of lanthanum","volume":"355","author":"Cerny","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2010.12.005_bib0245","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.ki.5002413","article-title":"The case: a peritoneal dialysis patient with an unusual abdominal film. Treatment with lanthanum carbonate","volume":"72","author":"Chuang","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0250","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/ndt\/gfm208","article-title":"Heavy metal\u2013rely on gut feelings: novel diagnostic approach to test drug compliance in patients with lanthanum intake","volume":"22","author":"David","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0255","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1093\/ndt\/gfp364","article-title":"Lanthanum deposition in a dialysis patient","volume":"24","author":"Davis","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0260","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2818.2006.01601.x","article-title":"Demonstration of lanthanum in liver cells by energy-dispersive X-ray spectroscopy, electron energy loss spectroscopy and high-resolution transmission electron microscopy","volume":"223","author":"Yang","year":"2006","journal-title":"J Microsc"},{"key":"10.1016\/j.nephro.2010.12.005_bib0265","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1523-1755.2005.00281.x","article-title":"Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate","volume":"67","author":"Behets","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0270","first-page":"428","article-title":"The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease","volume":"64","author":"Freemont","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0275","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","article-title":"Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1\u00a0year of treatment with lanthanum carbonate and after 2\u00a0years of follow-up","volume":"21","author":"Spasovski","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0280","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.ki.5001932","article-title":"Cognitive function in stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy","volume":"71","author":"Altmann","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0285","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1093\/ndt\/gfp340","article-title":"A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report","volume":"24","author":"Muller","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0290","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/ndt\/gfp508","article-title":"A confusional state associated with use of lanthanum carbonate in a dialysis patient: a case report","volume":"24","author":"Smyth","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0295","unstructured":"Haute Autorit\u00e9 de sant\u00e9, avis de la Commission de transparence, 12\u00a0avril\u00a02006. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/ct032555.pdf."},{"key":"10.1016\/j.nephro.2010.12.005_bib0300","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0305","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0310","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0315","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification \u2013 results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2010.12.005_bib0320","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.12.005_bib0325","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0330","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0335","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2010.12.005_bib0340","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2710.2007.00871.x","article-title":"Survival in end stage renal disease: calcium carbonate vs sevelamer","volume":"32","author":"Borzecki","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.nephro.2010.12.005_bib0345","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1185\/03007990903399398","article-title":"Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy","volume":"25","author":"Wilson","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nephro.2010.12.005_bib0350","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1093\/ndt\/gfp350","article-title":"The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis","volume":"24","author":"Jamal","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2010.12.005_bib0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials","volume":"54","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2010.12.005_bib0360","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0365","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2010.12.005_bib0370","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2215\/CJN.04741107","article-title":"Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725510002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2010.12.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:00:18Z","timestamp":1741186818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725510002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1769725510002579"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2010.12.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}